TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07158021: Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial

Sponsor: University of Michigan Rogel Cancer Center · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 75 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$14,784,000

Rescue Site Savings

+$9,748,200

Unlock Full NCT07158021 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07158021 Rescue Dossier →